葡萄牙人乳头瘤病毒疫苗接种规划对生殖器疣的流行病学影响:一项回顾性病历审查研究
在里斯本地区两家免费性传播疾病门诊开展回顾性病历审查,分析2006年5月至2017年12月首次就诊患者。2008至2017年,≤19岁和20-24岁女性生殖器疣患病率分别下降86.8%和77.4%,同年龄男性分别下降38.5%和19.3%;≥25岁患者患病率上升,沙眼衣原体感染总患病率上升75.9%。
要点
- 2008至2017年,≤19岁女性生殖器疣患病率下降86.8%,20-24岁女性下降77.4%。
- 同年龄段男性生殖器疣患病率分别下降38.5%和19.3%,降幅低于女性。
- ≥25岁女性生殖器疣患病率上升9.7%,男性上升14.7%;沙眼衣原体感染总患病率上升75.9%。
核心结论
- 本研究为公共HPV疫苗接种规划可有效降低疫苗适龄人群生殖器疣患病率增添证据。
- HPV疫苗接种规划可能显著减轻葡萄牙生殖器疣相关负担。
研究设计与样本
- 观察性、回顾性病历审查研究,在里斯本地区两家免费性传播疾病门诊开展。
- 审查2006年5月至2017年12月期间所有首次性传播疾病咨询患者的病历。
- 观察期分为疫苗接种前(2006年5月至2008年12月)和疫苗接种期(2009年1月至2017年12月)。
- 记录每年诊断为生殖器疣和/或沙眼衣原体感染的患者数,计算年患病率。
主要发现
- 大多数患者为男性(69.5%)且年龄≥25岁(78.1%)。
- 大多数男性患者为与女性发生性行为的男性(62.0%)。
- 2008年至2017年,≤19岁女性生殖器疣患病率下降86.8%,20-24岁女性下降77.4%。
- 同年龄段男性生殖器疣患病率分别下降38.5%和19.3%。
- ≥25岁女性生殖器疣患病率上升9.7%,男性上升14.7%;2008至2017年沙眼衣原体感染总患病率上升75.9%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The quadrivalent human papillomavirus (HPV) vaccine was introduced in the Portuguese National Immunization Program in October 2008, targeting 13-year-old girls. This study aimed at evaluating the impact of HPV vaccination on the epidemiology of genital warts (GWs) in Portugal. METHODS: Observational, retrospective chart review study conducted at two free-of-charge walk-in sexually transmitted diseases (STD) clinics in Lisbon region. The medical records of all patients attending a first STD consultation at the study centers between May 2006 and December 2017 (observation period) were reviewed. The number of patients diagnosed with GWs and/or chlamydial infection at each year was documented and used to determine yearly prevalence of both conditions throughout the observation period. We broke down the observation period into pre-vaccination (May 2006 to December 2008) and vaccination (January 2009 to December 2017) periods. RESULTS: Most patients were male (69.5%) and aged ≥ 25 years (78.1%). The majority of male patients were men who have sex with women (62.0%). Marked decreases in the prevalence of GWs between the last year of the pre-vaccination period (2008) and the last year of the observation period (2017) were found for female patients aged ≤ 19 and 20-24 years (86.8% and 77.4%, respectively). Lower decreases were observed for male patients of the same age groups (38.5% and 19.3%, respectively). GWs prevalence increased among patients ≥ 25 years (9.7% and 14.7% among female and male patients, respectively). Overall prevalence of chlamydial infection increased by 75.9% between 2008 and 2017. CONCLUSIONS: This study contributes to the body of evidence showing that public HPV vaccination programs are effective in reducing the prevalence of GWs among vaccine-eligible patients. HPV vaccination program may significantly reduce the burden associated with GWs in Portugal.
引用
- Fernandes C, Alves J, Rodrigues A, et al. Epidemiological impact of the human papillomavirus vaccination program on genital warts in Portugal: A retrospective, chart review study. Vaccine. 2021. PMID: 34953608. doi:10.1016/j.vaccine.2021.11.070
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。